Cited by 176Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers

Open access

Christiaans, Imke, van Engelen, Klaartje, van Langen, Irene M., Birnie, Erwin, Bonsel, Gouke J., Elliott, Perry M., Wilde, Arthur A.M.·2010·EP Europace

DOI 10.1093/europace/eup431

Open this paper in CoChat — free account

Abstract

We performed a systematic literature review of recommended 'major' and 'possible' clinical risk markers for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). We searched the Medline, Embase and Cochrane databases for articles published between 1971 and 2007. We included English language reports on HCM patients containing follow-up data on the endpoint (sudden) cardiac death using survival analysis. Analysis was undertaken using the quality of reporting of meta-analyses (QUORUM) statement checklist. The quality was checked using a quality assessment form from the Cochrane Collaboration. Thirty studies met inclusion criteria and passed quality assessment. The use of the six major risk factors (previous cardiac arrest or sustained ventricular tachycardia, non-sustained ventricular tachycardia, extreme left ventricular hypertrophy, unexplained syncope, abnormal blood pressure response, and family history of sudden death) in risk stratification for SCD as recommended by international guidelines was supported by the literature. In addition, left ventricular outflow tract obstruction seems associated with a higher risk of SCD. Our systematic review provides sound evidence for the use of the six major risk factors for SCD in the risk stratification of HCM patients. Left ventricular outflow tract obstruction could be included in the overall risk profile of patients with a marked left ventricular outflow gradient under basal conditions.

Integrity signals

Registry

Crossref · 10.1093/europace/eup431

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Contemporary Definitions and Classification of the Cardiomyopathies
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572
Hypertrophic Cardiomyopathy
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,276
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 802
Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 776
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H. C., Chudley, A. E., McKenna, W. J., Kristinsson, A., Roberts, R., Sole, M. J., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 757

Show all 69 references

Sorted by citations

2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
Hypertrophic Cardiomyopathy
Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya‐Mitjans, À., de Lange, F. J., Deharo, J., Elliot, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martiın, A., et al. (2018) · Kardiologia Polska · doi:10.5603/kp.2018.0161 · Cited by 475
Patterns of Disease Progression in Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Poggesi, C., & Yacoub, M. H. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967026 · Cited by 352
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Maron, B. J., Rowin, E. J., Casey, S. A., Link, M. S., Lesser, J. R., Chan, R. H. M., Garberich, R. F., Udelson, J. E., & Maron, M. S. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.061 · Cited by 317
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy
Maron, M. S., Rowin, E. J., Wessler, B. S., Mooney, P., Fatima, A., Patel, P. P., Koethe, B. C., Romashko, M. D., Link, M. S., & Maron, B. J. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1391 · Cited by 323
How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice
Maron, B. J., Rowin, E. J., Casey, S. A., & Maron, M. S. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0354 · Cited by 246
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry
Lipshultz, S. E., Orav, E. J., Wilkinson, J. D., Towbin, J. A., Messere, J. E., Lowe, A. M., Sleeper, L. A., Cox, G. F., Hsu, D. T., Canter, C. E., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61685-2 · Cited by 207
Heart Rate and Heart Rate Variability of Rhesus Macaques (Macaca mulatta) Affected by Left Ventricular Hypertrophy
Ueda, Y., Slabaugh, T. L., Walker, A. L., Ontiveros, E. S., Sosa, P.-M., Reader, J. R., Roberts, J. A., & Stern, J. A. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00001 · Cited by 195
Genetic testing for inherited cardiac disease
Wilde, A. A. M., & Behr, E. R. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.108 · Cited by 182
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
O’Mahony, C., Lambiase, P. D., Quarta, G., Cardona, M., Calcagnino, M. M., Tsovolas, K., Al-Shaikh, S., Rahman, S. M., Arnous, S., Jones, S., et al. (2011) · Heart · doi:10.1136/hrt.2010.217182 · Cited by 174
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy
O’Mahony, C., Tome, M., Lambiase, P. D., Pantazis, A. A., Dickie, S., McKenna, W. J., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2012-303271 · Cited by 159
Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice
Baig, S., Edward, N. C., Kotecha, D., Liu, B., Nordin, S., Kozor, R., Moon, J., Geberhiwot, T., & Steeds, R. P. (2017) · EP Europace · doi:10.1093/europace/eux261 · Cited by 134
Sudden Cardiac Death in Hypertrophic Cardiomyopathy
O’Mahony, C., Elliot, P. M., & McKenna, W. J. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962043 · Cited by 106
Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
To, A. C. Y., Dhillon, A. S., & Desai, M. Y. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.06.022 · Cited by 98
Systematic Review of Pregnancy in Women with Inherited Cardiomyopathies
Krul, S. P. J., van der Smagt, J. J., van den Berg, M. P., Sollie, K. M., Pieper, P. G., & van Spaendonck‐Zwarts, K. Y. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr040 · Cited by 92
Distinct ECG Phenotypes Identified in Hypertrophic Cardiomyopathy Using Machine Learning Associate With Arrhythmic Risk Markers
Lyon, A., Ariga, R., Mincholé, A., Mahmod, M., Ormondroyd, E., Laguna, P., de Freitas, N., Neubauer, S., Watkins, H. C., & Rodríguez, B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00213 · Cited by 85
Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy
Rowin, E. J., Maron, M. S., Chan, R. H. M., Hausvater, A., Wang, W., Rastegar, H., & Maron, B. J. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.048 · Cited by 76
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy
Smole, T., Žunkovič, B., Pičulin, M., Kokalj, E., Robnik‐Šikonja, M., Kukar, M., Fotiadis, D. I., Pezoulas, V. C., Tachos, N. S., Barlocco, F., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104648 · Cited by 77
Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy
Maron, B. J., & Maron, M. S. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.048 · Cited by 74
Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model)
Bhattacharya, M., Lu, D., Kudchadkar, S. M., Greenland, G. V., Lingamaneni, P., Corona‐Villalobos, C. P., Guan, Y., Marine, J. E., Olgin, J. E., Zimmerman, S. L., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.02.022 · Cited by 70
Female Sex Is Associated with Worse Prognosis in Patients with Hypertrophic Cardiomyopathy in China
Wang, Y., Wang, J., Zou, Y., Bao, J., Sun, K., Zhu, L., Tian, T., Hu, S., Zhou, X., Ahmad, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102969 · Cited by 71
Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy
Ismail, T. F., Prasad, S. K., & Pennell, D. J. (2011) · Heart · doi:10.1136/heartjnl-2011-300814 · Cited by 62
Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM)
Marian, A. J., Tan, Y., Li, L., Chang, J., Syrris, P., Hessabi, M., Rahbar, M. H., Willerson, J. T., Cheong, B., Liu, C., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312647 · Cited by 61
Prevention of sudden death in hypertrophic cardiomyopathy: bridging the gaps in knowledge
Weissler‐Snir, A., Adler, A., Williams, L. K., Gruner, C., & Rakowski, H. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw268 · Cited by 59
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy
Montoro‐García, S., Hernández‐Romero, D., Jover, E., García‐Honrubia, A., Vilchez, J. A., Casas, T., Martı́nez, P., Climent, V. E., Caballero, L., Valdés, M., et al. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.08.022 · Cited by 52
Publication guidelines need widespread adoption
Larson, E., & Cortazal, M. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.07.008 · Cited by 50
Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings
Soler, R., Méndez, C., Rodrı́guez, E., Villa, R. B., Ochoa, J. P., & Monserrat, L. (2018) · Insights into Imaging · doi:10.1007/s13244-018-0656-8 · Cited by 51
Fragmented QRS as a predictor of arrhythmic events in patients with hypertrophic obstructive cardiomyopathy
on behalf of Fragmented QRS in Hypertrophic Obstructive Cardiomyopathy (FHOCM) Study Investigators, Femenía, F., Arce, M. A., Grieken, J. V., Trucco, E., Mont, L., Abello, M., Merino, J. L., Rivero‐Ayerza, M., Görenek, B., et al. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9829-z · Cited by 49
Genetics and Genomics of Single-Gene Cardiovascular Diseases
Marian, A. J., van Rooij, E., & Roberts, R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.968 · Cited by 48
Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy
Kang, K., Janardhan, A. H., Jung, K. T., Lee, H. S., Lee, M., & Hwang, H. J. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.05.002 · Cited by 47
Anacardic acid attenuates pressure‐overload cardiac hypertrophy through inhibiting histone acetylases
Li, S., Peng, B., Luo, X., Sun, H., & Peng, C. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14181 · Cited by 45
Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes
Garratt, C. J., Elliot, P. M., Behr, E. R., Camm, A. J., Cowan, C., Cruickshank, S., Grace, A. A., GRIFFITH, M. J., Jolly, A., Lambiase, P. D., et al. (2010) · EP Europace · doi:10.1093/europace/euq261 · Cited by 43
Predictors of risk for sudden death in childhood hypertrophic cardiomyopathy: the importance of the ECG risk score
Östman‐Smith, I., Sjöberg, G., Rydberg, A., Larsson, P., & Fernlund, E. (2017) · Open Heart · doi:10.1136/openhrt-2017-000658 · Cited by 39
Prevention of sudden cardiac death in hypertrophic cardiomyopathy
O’Mahony, C., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2012-301996 · Cited by 36
Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy
Weissler‐Snir, A., Chan, R. H. M., Adler, A., Care, M. E., Chauhan, V. S., Gollob, M. H., Ziv‐Baran, T., Fourey, D., Hindieh, W., Rakowski, H., et al. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.043 · Cited by 34
High Signal Intensity on T2-Weighted Cardiovascular Magnetic Resonance Imaging Predicts Life-Threatening Arrhythmic Events in Hypertrophic Cardiomyopathy Patients
Hen, Y., Takara, A., Iguchi, N., Utanohara, Y., Teraoka, K., Takada, K., Machida, H., Takamisawa, I., Takayama, M., & Yoshikawa, T. (2018) · Circulation Journal · doi:10.1253/circj.cj-17-1235 · Cited by 31
Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator
Salas, A. R., García‐Pinilla, J. M., Cabrera‐Bueno, F., Fernández-Pastor, J., Peña-Hernández, J., Medina-Palomo, C., Barrera-Cordero, A., de Teresa, E., & Alzueta, J. (2015) · EP Europace · doi:10.1093/europace/euv079 · Cited by 30
Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy
Thavikulwat, A. C., Tomson, T. T., Knight, B. P., Bonow, R. O., & Choudhury, L. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13005 · Cited by 30
Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning
Kochav, S. M., Raita, Y., Fifer, M. A., Takayama, H., Ginns, J. N., Maurer, M. S., Reilly, M. P., Hasegawa, K., & Shimada, Y. J. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.11.003 · Cited by 30
The role of renin–angiotensin–aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy
Kolder, I. C. R. M., Michels, M., Christiaans, I., ten Cate, F. J., Majoor‐Krakauer, D. F., Danser, A. H. J., Deprez, R. H. L., Tanck, M. W. T., Wilde, A. A. M., Bezzina, C. R., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.48 · Cited by 29
The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast‐enhanced magnetic resonance study
Weissler‐Snir, A., Hindieh, W., SPEARS, D. A., Adler, A., Rakowski, H., & Chan, R. H. M. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13855 · Cited by 29
Prevalence of HCM and long QT syndrome mutations in young sudden cardiac death-related cases
Allegue, C., Gil, R., Blanco‐Verea, A., Santori, M., Rodríguez-Calvo, M. S., Concheiro, L., Carracedo, Á., & Brión, M. (2011) · International Journal of Legal Medicine · doi:10.1007/s00414-011-0572-7 · Cited by 28
Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy
Patel, V., Critoph, C., Finlay, M., Mist, B., Lambiase, P. D., & Elliot, P. M. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.062 · Cited by 27
Role of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Systematic Review and Updated Meta-Analysis of Risk Markers for Sudden Death
Bittencourt, M. I., Cader, S. A., Araújo, D. V., Salles, A. L. F., Albuquerque, F. N., Spineti, P. P. D. M., de Albuquerque, D. C., & Mourilhe‐Rocha, R. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190045 · Cited by 27
Holter monitoring demonstrates that ventricular arrhythmias are common in cats with decompensated and compensated hypertrophic cardiomyopathy
Bartoszuk, U., Keene, B. W., Toaldo, M. B., Pereira, N., Summerfield, N., Matos, J. N., & Glaus, T. M. (2018) · The Veterinary Journal · doi:10.1016/j.tvjl.2018.11.005 · Cited by 26
Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy
Santoro, F., Mango, F., Mallardi, A., D’Alessandro, D., Casavecchia, G., Gravina, M., Correale, M., & Brunetti, N. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12103397 · Cited by 26
Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults
Loar, R. W., Bos, J. M., Will, M. L., Ommen, S. R., & Ackerman, M. J. (2015) · Congenital Heart Disease · doi:10.1111/chd.12280 · Cited by 28
Demographic and Regional Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999 to 2019
Minhas, A. M. K., Wyand, R. A., Ariss, R. W., Nazir, S., Khan, M. S., Jia, X., Greene, S. J., Fudim, M., Wang, A., Warraich, H. J., et al. (2022) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.009292 · Cited by 25
Burden and trends of arrhythmias in hypertrophic cardiomyopathy and its impact of mortality and resource utilization
Tripathi, B., Khan, S. U., Arora, S., Kumar, V. M., Naraparaju, V., Lahewala, S., Sharma, P., Atti, V., Jain, V., Shah, M. K., et al. (2019) · Journal of Arrhythmia · doi:10.1002/joa3.12215 · Cited by 23
Importance of newer cardiac magnetic resonance–based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study
Rowin, E. J., Maron, M. S., Adler, A., Albano, A. J., Varnava, A. M., SPEARS, D. A., Marsy, D., Heitner, S. B., Cohen, E., Leong, K. M. W., et al. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.12.017 · Cited by 24
Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
Jordà, P., & García‐Álvarez, A. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.25 · Cited by 22
Sports and Exercise in Athletes with Hypertrophic Cardiomyopathy
Alpert, C. M., Day, S. M., & Saberi, S. (2015) · Clinics in Sports Medicine · doi:10.1016/j.csm.2015.03.005 · Cited by 25
Post-Mortem Imaging Adjudicated Sudden Death: Causes and Controversies
Femia, G., Semsarian, C., Langlois, N. E. I., McGuire, M. A., Raleigh, J., Taylor, A. M., & Puranik, R. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.09.003 · Cited by 22
Comparison of 3D Phase-Sensitive Inversion-Recovery and 2D Inversion-Recovery MRI at 3.0 T for the Assessment of Late Gadolinium Enhancement in Patients with Hypertrophic Cardiomyopathy
Morita, K., Utsunomiya, D., Oda, S., Komi, M., Namimoto, T., Hirai, T., Hashida, M., Takashio, S., Yamamuro, M., & Yamashita, Y. (2013) · Academic Radiology · doi:10.1016/j.acra.2013.01.014 · Cited by 21
Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator
Francia, P., Ziacchi, M., Adduci, C., Ammendola, E., Pieragnoli, P., Filippo, P. D., Rapacciuolo, A., Rella, V., Migliore, F., Viani, S. M., et al. (2023) · EP Europace · doi:10.1093/europace/euad270 · Cited by 20
Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part II: potentially malignant and benign ventricular arrhythmias.
Gatzoulis, K. A., Archontakis, S., Dilaveris, P., Tsiachris, D., Αρσένος, Π., Sideris, S. K., & Stefanadis, C. (2012) · PubMed · Cited by 19
Risk Stratification in Hypertrophic Cardiomyopathy
Steriotis, A. K., & Sharma, S. (2015) · European Cardiology Review · doi:10.15420/ecr.2015.10.01.31 · Cited by 20
Distribution and Clinical Significance of High Signal Intensity of the Myocardium on T2-Weighted Images in 2 Phenotypes of Hypertrophic Cardiomyopathy
Amano, Y., Aita, K., Yamada, F., Kitamura, M., & Kumita, S. (2015) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000296 · Cited by 20
Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
Maron, M. S., Rowin, E. J., Spirito, P., & Maron, B. J. (2022) · Heart · doi:10.1136/heartjnl-2020-316693 · Cited by 19
Role of echocardiography in the diagnosis and management of hypertrophic cardiomyopathy
Domínguez, F., González-López, E., Padrón-Barthe, L., Cavero, M. A., & García‐Pavía, P. (2017) · Heart · doi:10.1136/heartjnl-2016-310559 · Cited by 18
Strategies for the prevention and treatment of sudden cardiac death
Herzog, E., Javed, F., & Aziz, E. F. (2010) · Open Access Emergency Medicine · doi:10.2147/oaem.s6869 · Cited by 17
Holter Monitoring and Long-Term Prognosis in Hypertrophic Cardiomyopathy
Kawasaki, T., Sakai, C., Harimoto, K., Yamano, M., Miki, S., Kamitani, T., & Sugihara, H. (2012) · Cardiology · doi:10.1159/000338156 · Cited by 18
Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy
Raiker, N. K., Vullaganti, S., Collins, J. D., Allen, B. D., & Choudhury, L. (2020) · International journal of cardiac imaging · doi:10.1007/s10554-020-01808-6 · Cited by 17
Risk assessment in hypertrophic cardiomyopathy: contemporary guidelines hampered by insufficient evidence
McKeown, P., & Muir, A. (2013) · Heart · doi:10.1136/heartjnl-2012-303363 · Cited by 15
Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death
Smith, E. D., Tome, J., McGrath, R., Kumar, S., Concannon, M., Day, S. M., Saberi, S., & Helms, A. S. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.07.110 · Cited by 15
Abnormal sodium channel mRNA splicing in hypertrophic cardiomyopathy
Noyes, A. M., Zhou, A., Gao, G., Gu, L., Day, S. M., Wasserstrom, J. A., & Dudley, S. C. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.08.071 · Cited by 15
Alcohol septal ablation in patients with severe septal hypertrophy
Veselka, J., Jensen, M. K., Liebregts, M., Cooper, R. M., Januška, J., Kashtanov, M. G., Dąbrowski, M., Hansen, P. R., Seggewiß, H., Hansvenclová, E., et al. (2019) · Heart · doi:10.1136/heartjnl-2019-315422 · Cited by 15
LEOPARD Syndrome Caused by Tyr279Cys Mutation in the PTPN11 Gene
Martínez‐Quintana, E., & Rodríguez-González, F. (2011) · Molecular Syndromology · doi:10.1159/000335995 · Cited by 15
Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy
Amano, M., Kitaoka, H., Yoshikawa, Y., Sakata, Y., Dohi, K., Tokita, Y., Kato, T., Matsushima, S., Kitai, T., Okada, A., et al. (2025) · JACC Heart Failure · doi:10.1016/j.jchf.2024.12.006 · Cited by 14
Risk stratification in hypertrophic cardiomyopathy
Marrakchi, S., Kammoun, I., Bennour, E., Laroussi, L., & Kachboura, S. (2018) · Herz · doi:10.1007/s00059-018-4700-8 · Cited by 14
Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy
Maron, M. S. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.05.004 · Cited by 13
Surface fragmented QRS in a patient with hypertrophie cardiomyopathy and malignant arrhythmias: ls there an association?
Femenía, F., Arce, M., Arrieta, M., & Baranchuk, A. M. (2012) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.91602 · Cited by 13
Cardiac MRI evaluation of hypertrophic cardiomyopathy: Left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction
Vogel‐Claussen, J., Tomas, M. S., Newatia, A., Boyce, D. M., Pinheiro, A. C., Abraham, R. M., Abraham, T. P., & Bluemke, D. A. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23677 · Cited by 13
Supraventricular tachycardia in 23 cats; comparison with 21 cats with atrial fibrillation (2004–2014)
Greet, V., Sargent, J., Brannick, M., & Fuentes, V. L. (2020) · Journal of Veterinary Cardiology · doi:10.1016/j.jvc.2020.04.007 · Cited by 12
Extended ambulatory ECG monitoring enhances identification of higher-risk ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy
Rowin, E. J., Das, G., Madias, C. A., Hsu, M., Crosson, L. A., Turakhia, M. P., Maron, B. J., & Maron, M. S. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.09.040 · Cited by 12
Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
Du, D., Li, C. O. Y., Ong, K., Parsa, A., Weissler‐Snir, A., Geske, J. B., & Laksman, Z. (2022) · CJC Open · doi:10.1016/j.cjco.2022.01.001 · Cited by 11
HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY
Vatutin, N. T., Тарадин, Г. Г., & Maron, M. S. (2014) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2014-5-35-42 · Cited by 11
Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY)
Mirabel, M., Damy, T., Donal, E., Huttin, O., Labombarda, F., Eicher, J., Cervino, C. O., Laurito, M., Offredo, L., Tafflet, M., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.09.083 · Cited by 11
The relationship between β1‐adrenergic and M2‐muscarinic receptor autoantibodies and hypertrophic cardiomyopathy
Duan, X., Liu, R., Luo, X., Gao, X., Hu, F., Guo, C., Wang, J., Hu, X., Chun, Y., Yuan, J., et al. (2019) · Experimental Physiology · doi:10.1113/ep088263 · Cited by 11
Hypertrophic Cardiomyopathy: Challenging the Status Quo?
Younger, J. F., Lo, A., McCormack, L., McGaughran, J. M., Prasad, S. B., & Atherton, J. J. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.12.005 · Cited by 10
Rapid Device‐Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy
VISWANATHAN, K., Suszko, A. M., Das, M., Jackson, N. M., Gollob, M. H., CAMERON, D. A., SPEARS, D. A., Woo, A., Rakowski, H., Khurana, M., et al. (2016) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12861 · Cited by 10
Incremental Value of an Insertable Cardiac Monitor in Patients with Hypertrophic Cardiomyopathy with Low or Intermediate Risk for Sudden Cardiac Death
Sakhi, R., Huurman, R., Theuns, D. A. M. J., Schinkel, A. F. L., Assaf, A., Szili‐Törok, T., Roos‐Hesselink, J. W., Michels, M., & Yap, S. (2021) · Cardiology · doi:10.1159/000512656 · Cited by 10
Terapia con desfibrilador automático implantable en la miocardiopatía hipertrófica: utilidad en prevención primaria y secundaria
Sarrias, A., Galve, E., Sabaté, X., Moya‐Mitjans, À., Anguera, I., Núñez, E., Villuendas, R., Alcalde, Ó., & David Garcia-dorado, A. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.05.024 · Cited by 9
Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy
Zhai, S., Xu, H., Fan, C., Yang, Y., Hang, F., Guo, X., Wang, H., Duan, F., & Yan, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192218 · Cited by 9
Epidemiology of Heart Failure
Dahlström, U. (2019) · Cardiovascular medicine · doi:10.1007/978-3-319-98184-0_1 · Cited by 8
Additive prognostic significance of ejection fraction for ESC risk model in hypertrophic cardiomyopathy patients
Hen, Y., Iguchi, N., Kanisawa, M., Takada, K., Machida, H., Takara, A., Teraoka, K., Takamisawa, I., Takayama, M., & Yoshikawa, T. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01496-w · Cited by 8
Almanac 2014: cardiomyopathies
Guttmann, O. P., MOHIDDIN, S. A., & Elliot, P. M. (2014) · Heart · doi:10.1136/heartjnl-2013-305420 · Cited by 8
Risk stratification in hypertrophic cardiomyopathy
Pacileo, G., Salerno, G., Gravino, R., Calabrò, R., & Elliot, P. M. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328357739e · Cited by 7
The Role of Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy
Marchesini, M., Uguccioni, L., Parisi, R., Mattioli, G., Terzi, F., Olivieri, R., Capucci, A., & Fattori, R. (2016) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0811 · Cited by 7
Risk Factors for Sudden Death in Athletes, Is There a Role for Screening?
HAJDUCZOK, A. G., Ruge, M., & Emery, M. S. (2022) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-022-00697-9 · Cited by 9
Hypertrophic cardiomyopathy
Östman‐Smith, I., Rossano, J. W., & Shaddy, R. E. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835dd020 · Cited by 7
Risk factors for sudden cardiac death to determine high risk patients in specific patient populations that may benefit from a wearable defibrillator
Khan, H., & Leslie, S. J. (2019) · World Journal of Cardiology · doi:10.4330/wjc.v11.i3.103 · Cited by 7
Discordância entre Diretrizes Internacionais sobre Critérios de Prevenção Primária de Morte Súbita na Cardiomiopatia Hipertrófica
Mattos, B. P. E., Scolari, F. L., & Garbin, H. I. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190161 · Cited by 7
PET-CT Imaging in Hypertrophic Cardiomyopathy: A Narrative Review on Risk Stratification and Prognosis
Marques‐Alves, P., Gonçalves, L. M. M., & Ferreira, M. J. (2025) · Diagnostics · doi:10.3390/diagnostics15020133 · Cited by 6
Evaluation of sudden cardiac death in hypertrophic cardiomyopathy
Yoon, S. G., & Hong, G. (2025) · Journal of Cardiovascular Imaging · doi:10.1186/s44348-025-00054-5 · Cited by 7
Demographics and Trends of Hypertrophic Cardiomyopathy-Related Mortality in the United States, 1999-2020
Renjihtlal, S. L. M., Eid, M., Vyas, C., Mohamed, S., Shanmukhappa, S., Renjith, K., Mostafa, M. R., Baibhav, B., & Pillai, N. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101681 · Cited by 6
Prognostic value of cardiovascular magnetic resonance imaging for life-threatening arrhythmia detected by implantable cardioverter-defibrillator in Japanese patients with hypertrophic cardiomyopathy
Hen, Y., Tsugu-Yagawa, M., Iguchi, N., Utanohara, Y., Takada, K., Machida, H., Takara, A., Teraoka, K., Inoue, K., Takamisawa, I., et al. (2017) · Heart and Vessels · doi:10.1007/s00380-017-1030-3 · Cited by 6
Prognostic impact of mitral L-wave in patients with hypertrophic cardiomyopathy without risk factors for sudden cardiac death
Sugiura, Y., Morimoto, R., Aoki, S., Yamaguchi, S., Haga, T., Kuwayama, T., Yokoi, T., Hiraiwa, H., Kondo, T., Watanabe, N., et al. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01440-y · Cited by 5

Authors: Christiaans, I., van Engelen, K., van Langen, I. M., Birnie, E., Bonsel, G. J., Elliott, P. M., & Wilde, A. A. M.
Affiliations: Amsterdam UMC Location University of Amsterdam (NL)
Erasmus MC (NL)
Corresponding author: Wilde, Arthur A.M.
ORCID: Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Wilde, Arthur A.M.
Venue: EP Europace
Publisher: Oxford University Press (OUP)
Published: 2010-01-29
Volume: 12
Issue: 3
Pages: 313-321
ISSN: 1099-5129 (ISSN-L)
1532-2092
DOI: 10.1093/europace/eup431
OpenAlex: W2120813609
Cited by: 176
References: 69
Citations by year: 2026: 3 · 2025: 10 · 2024: 3 · 2023: 5 · 2022: 8 · 2021: 5 · 2020: 7 · 2019: 18 · 2018: 20 · 2017: 13 · 2016: 13 · 2015: 13 · 2014: 8 · 2013: 16 · 2012: 15
FWCI: 2.61
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
Locations: EP Europace (publishedVersion)
PubMed (publishedVersion)
Pure Amsterdam UMC (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, sudden cardiac death, risk stratification, left ventricular outflow tract obstruction, left ventricular hypertrophy, ventricular tachycardia, syncope, family history of sudden death, blood pressure response, cardiac arrest
MeSH terms: Cardiomyopathy, Hypertrophic, Humans, Prognosis, Risk Factors, Death, Sudden, Cardiac, Practice Guidelines as Topic, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks